Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Govt to amend norms in...

    Govt to amend norms in 15 days for fixing prices of 350 drugs

    Written by savita thakur thakur Published On 2016-08-30T09:37:11+05:30  |  Updated On 30 Aug 2016 9:37 AM IST
    Govt to amend norms in 15 days for fixing prices of 350 drugs

    New Delhi : Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said.


    Addressing the foundation day of the National Pharmaceutical Pricing Authority (NPPA), the Chemicals and Fertiliser Minister said the prices of nearly 900 medicines have been fixed under the Drugs (Prices Control) Order, (DPCO) 2013 resulting in a saving of about Rs 5,000 crore to consumers.


    The pricing of another 368 new formulations has also been fixed, he added.


    "For about 350 medicines which are under the National List of Essential Medicines (NLEM) we are not getting any market data. To bring them under the price control, we need to tweak the DPCO. In next 15 days, we are going to make the amendment to empower the NPPA," Kumar said.


    He said the government would not be a "mute spectator" and will regulate the prices of these 350 items as well.


    The minister further said the NPPA would fix the prices of all the remaining medicines in NLEM in a couple of months.


    Calling pharma as the 'sunrise industry' which is growing at a rapid pace, Kumar said the size of the Indian pharma industry is likely to cross USD 50 billion in the next three years from USD 35 billion in 2015.


    He noted that 100 per cent FDI has been allowed in pharma sectors, including brownfield projects.


    In order to make medicines available at an affordable price, the minister said the government is targeting to open 3,000 Jan Aushadhi stores across the country. At present, there are over 400 stores.


    Expressing concerns over the low consumption of medicines by people living below the poverty line, Kumar said there is a need for the NPPA to intervene and regulate the market to make essential drugs affordable to poor as well as producing and making generic drugs available to them.


    Kumar also launched a new mobile app 'Pharma Sahi Daam' that will help customers to know the price of medicines fixed by the NPPA. The minister expects this new initiative to be a huge success.


    The minister also pitched for making a separate ministry for the pharma sector. He would also request the Prime Minister to declare August 29, the foundation day of NPPA, as 'Rashtriya Jan Aushadhi Divas'.


    Emphasising on making the Indian pharma sector globally competitive, Kumar said the government is developing pharma parks and medical devices parks which will reduce the production cost.

    Ananth KumarDPCODrugs Prices Control Orderfixing pricesNational List of Essential MedicinesNLEM
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok